Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification
- 21 November 2003
- journal article
- clinical trial
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 73 (1) , 11-22
- https://doi.org/10.1016/j.drugalcdep.2003.08.006
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Assessing abuse liability in clinical trialsDrug and Alcohol Dependence, 2003
- A controlled trial of buprenorphine treatment for opium dependence: the first experience from IranDrug and Alcohol Dependence, 2001
- Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patientsPsychopharmacology, 1999
- Plasma concentrations of buprenorphine 24 to 72 hours after dosingPublished by Elsevier ,1999
- Outpatient Opiate Detoxification Treatment with BuprenorphineEuropean Addiction Research, 1998
- Abuse of Prescription Medicines in Southwestern FranceAnnals of Pharmacotherapy, 1997
- Buprenorphine treatment of opioid dependence: A review.Experimental and Clinical Psychopharmacology, 1995
- Alternate-day dosing during buprenorphine treatment of opioid dependenceLife Sciences, 1994
- A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addictsClinical Pharmacology & Therapeutics, 1988
- Buprenorphine kineticsClinical Pharmacology & Therapeutics, 1980